Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Apr 16;61(15):1596-600.
doi: 10.1016/j.jacc.2012.12.045.

Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study

Affiliations
Free article
Clinical Trial

Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study

Giora Weisz et al. J Am Coll Cardiol. .
Free article

Abstract

Objectives: The aim of this study was to evaluate the safety as well as the clinical and technical effectiveness of robotic-assisted percutaneous coronary intervention.

Background: Robotic systems have been suggested to enhance the performance of cardiovascular procedures, as well as to provide protection from the occupational hazards that are associated with interventional practice.

Methods: Patients with coronary artery disease and clinical indications for percutaneous intervention were enrolled. The coronary intervention was performed with the CorPath 200 robotic system, which consists of a remote interventional cockpit and a bedside disposable cassette that enables the operator to advance, retract, and rotate guidewires and catheters. The primary endpoints were clinical procedural success, defined as <30% residual stenosis at the completion of the robotic-assisted procedure without major adverse cardiovascular events within 30 days, and device technical success, defined as the successful manipulation of the intracoronary devices using the robotic system only.

Results: A total of 164 patients were enrolled at 9 sites. Percutaneous coronary intervention was completed successfully without conversion to manual operation, and device technical success was achieved in 162 of 164 patients (98.8%). There were no device-related complications. Clinical procedural success was achieved in 160 of 164 patients (97.6%), whereas 4 (2.4%) had periprocedural non-Q-wave myocardial infarctions. No deaths, strokes, Q-wave myocardial infarctions, or revascularization occurred in the 30 days after the procedures. Radiation exposure for the primary operator was 95.2% lower than the levels found at the traditional table position.

Conclusions: This pivotal multicenter study with a robotic-enhanced coronary intervention system demonstrated the safety and feasibility of the system. The robotic remote-control procedure met the expected technical and clinical performance, with significantly lower radiation exposure to the operator. (Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions [PCI] [PRECISE]; NCT01275092).

Similar articles

See all similar articles

Cited by 18 articles

  • Radiation protection in the cardiac catheterization laboratory.
    Biso SMR, Vidovich MI. Biso SMR, et al. J Thorac Dis. 2020 Apr;12(4):1648-1655. doi: 10.21037/jtd.2019.12.86. J Thorac Dis. 2020. PMID: 32395308 Free PMC article. Review.
  • The Future of Stroke Interventions.
    Abergel E. Abergel E. Rambam Maimonides Med J. 2020 Apr 29;11(2):e0018. doi: 10.5041/RMMJ.10404. Rambam Maimonides Med J. 2020. PMID: 32374255 Free PMC article. Review.
  • First-in-human, robotic-assisted neuroendovascular intervention.
    Mendes Pereira V, Cancelliere NM, Nicholson P, Radovanovic I, Drake KE, Sungur JM, Krings T, Turk A. Mendes Pereira V, et al. J Neurointerv Surg. 2020 Apr;12(4):338-340. doi: 10.1136/neurintsurg-2019-015671.rep. Epub 2020 Mar 3. J Neurointerv Surg. 2020. PMID: 32132138 Free PMC article.
  • Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019.
    Lopes MACQ, Oliveira GMM, Ribeiro ALP, Pinto FJ, Rey HCV, Zimerman LI, Rochitte CE, Bacal F, Polanczyk CA, Halperin C, Araújo EC, Mesquita ET, Arruda JA, Rohde LEP, Grinberg M, Moretti M, Caramori PRA, Botelho RV, Brandão AA, Hajjar LA, Santos AF, Colafranceschi AS, Etges APBDS, Marino BCA, Zanotto BS, Nascimento BR, Medeiros CR, Santos DVV, Cook DMA, Antoniolli E, Souza Filho EM, Fernandes F, Gandour F, Fernandez F, Souza GEC, Weigert GS, Castro I, Cade JR, Figueiredo Neto JA, Fernandes JL, Hadlich MS, Oliveira MAP, Alkmim MB, Paixão MCD, Prudente ML, Aguiar Netto MAS, Marcolino MS, Oliveira MA, Simonelli O, Lemos Neto PA, Rosa PRD, Figueira RM, Cury RC, Almeida RC, Lima SRF, Barberato SH, Constancio TI, Rezende WF. Lopes MACQ, et al. Arq Bras Cardiol. 2019 Nov;113(5):1006-1056. doi: 10.5935/abc.20190205. Arq Bras Cardiol. 2019. PMID: 31800728 Free PMC article. No abstract available.
  • Cath Lab Robotics: Paradigm Change in Interventional Cardiology?
    Wegermann ZK, Swaminathan RV, Rao SV. Wegermann ZK, et al. Curr Cardiol Rep. 2019 Aug 31;21(10):119. doi: 10.1007/s11886-019-1218-5. Curr Cardiol Rep. 2019. PMID: 31473815 Review.
See all "Cited by" articles

Publication types

MeSH terms

Associated data

Feedback